Current Status of Therapy for Local Recurrence of Rectal Cancer_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 兰平 , 肖健 , 何晓生

Corresponding author：

兰平, Email: lanping@mail.sysu.edu.cn

Keywords：

局部复发直肠癌; 手术治疗; 放射治疗; 药物治疗; 多学科综合治疗

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 兰平,肖健,何晓生. Current Status of Therapy for Local Recurrence of Rectal Cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2013, 20(11): 1205-1207. doi: Copy

1.	Ferlay J， Shin HR， Bray F， et al. Estimates of worldwide burden of cancer in 2008：GLOBOCAN 2008[J]. Int J Cancer， 2010， 127(12)：2893-2917. doi：10. 1002/ijc. 25516.
2.	陈孝平，汪建平. 外科学[M]. 第8版. 北京：人民卫生出版社， 2013.
3.	Yu TK， Bhosale PR， Crane CH， et al. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer[J]. Int J Radiat Oncol Biol Phys， 2008， 71(4)：1175-1180.
4.	Pescatori M著，傅传刚，陆建平，李卫萍，等译. 盆底与肛管直肠疾病影像学图谱(翻译版)[J]. 北京：人民军医出版社：2010：137-139.
5.	Bipat S， Glas AS， Slors FJ， et al. Rectal cancer：local staging and assessment of lymph node involvement with endoluminal US， CT， and MR imaging—a meta-analysis[J]. Radiology， 2004， 232(3)：773-783.
6.	Boyle KM， Sagar PM， Chalmers AG， et al. Surgery for locally recurrent rectal cancer[J]. Dis Colon Rectum， 2005， 48(5)：929-937.
7.	Wiig JN， Tveit KM， Poulsen JP， et al. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study[J]. Radiother Oncol， 2002， 62(2)：207-213.
8.	Heriot AG， Byrne CM， Lee P， et al. Extended radical resection：the choice for locally recurrent rectal cancer[J]. Dis Colon Rectum，.
9.	Moore HG， Shoup M， Riedel E， et al. Colorectal cancer pelvic recurrences：determinants of resectability[J]. Dis Colon Rectum，.
10.	Akasu T， Yamaguchi T， Fujimoto Y， et al. Abdominal sacral resection for posterior pelvic recurrence of rectal carcinoma：ana-lyses of prognostic factors and recurrence patterns[J]. Ann Surg Oncol， 2007， 14(1)：74-83.
11.	Dozois EJ， Privitera A， Holubar SD， et al. High sacrectomy forlocally recurrent rectal cancer：Can long-term survival be achieved?[J]. J Surg Oncol， 2011， 103(2)：105-109.
12.	Dresen RC， Gosens MJ， Rutten HJ. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer[J]. Ann Surg Oncol， 2008， 15(7)：1937-1947.
13.	Valentini V， Morganti AG， Gambacorta MA， et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancerin patients previously irradiated to the pelvis：A multicentric phaseⅡstudy[J]. Int J Radiat Oncol Biol Phys， 2006， 64(4)：1129-1139.
14.	Das P， Delclos ME， Skibber JM， et al. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation[J]. Int J Radiat Oncol Biol Phys， 2010， 77(1)：60-65.
15.	卫生部医政司. 结直肠癌诊疗规范(2010年版)[J/CD]. 中国医学前沿杂志：电子版， 2011， 3(6)：130-146.
16.	van Gijn W， Marijnen CA， Nagtegaal ID， et al. Preoperativeradiotherapy combined with total mesorectal excision for resectablerectal cancer：12-year follow-up of the multicentre， randomised controlled TME trial[J]. Lancet Oncol， 2011， 12(6)：575-582.
17.	Sauer R， Becker H， Hohenberger W， et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer[J]. N Engl J Med， 2004， 351(17)：1731-1740.
18.	Grothey A， Sargent D， Goldberg RM， et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin， irinotecan， and oxaliplatin in the course of treatment[J]. J Clin Oncol， 2004， 22(7)：1209-1214.
19.	Gérard JP， Conroy T， Bonnetain F， et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers：results of FFCD 9203[J]. J Clin Oncol， 2006， 24(28)：4620-4625.
20.	De Caluwé L， Van Nieuwenhove Y， Ceelen WP. Preoperative chemoradiation versus radiation alone for stage Ⅱ and Ⅲ resectable rectal cancer[J]. Cochrane Database Syst Rev， 2013， 2：CD006041. doi：10. 1002/14651858. CD006041. pub3.
21.	， 47(10)：1599-1606.
22.	， 51(3)：284-291.

1. Ferlay J， Shin HR， Bray F， et al. Estimates of worldwide burden of cancer in 2008：GLOBOCAN 2008[J]. Int J Cancer， 2010， 127(12)：2893-2917. doi：10. 1002/ijc. 25516.
2. 陈孝平，汪建平. 外科学[M]. 第8版. 北京：人民卫生出版社， 2013.
3. Yu TK， Bhosale PR， Crane CH， et al. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer[J]. Int J Radiat Oncol Biol Phys， 2008， 71(4)：1175-1180.
4. Pescatori M著，傅传刚，陆建平，李卫萍，等译. 盆底与肛管直肠疾病影像学图谱(翻译版)[J]. 北京：人民军医出版社：2010：137-139.
5. Bipat S， Glas AS， Slors FJ， et al. Rectal cancer：local staging and assessment of lymph node involvement with endoluminal US， CT， and MR imaging—a meta-analysis[J]. Radiology， 2004， 232(3)：773-783.
6. Boyle KM， Sagar PM， Chalmers AG， et al. Surgery for locally recurrent rectal cancer[J]. Dis Colon Rectum， 2005， 48(5)：929-937.
7. Wiig JN， Tveit KM， Poulsen JP， et al. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study[J]. Radiother Oncol， 2002， 62(2)：207-213.
8. Heriot AG， Byrne CM， Lee P， et al. Extended radical resection：the choice for locally recurrent rectal cancer[J]. Dis Colon Rectum，.
9. Moore HG， Shoup M， Riedel E， et al. Colorectal cancer pelvic recurrences：determinants of resectability[J]. Dis Colon Rectum，.
10. Akasu T， Yamaguchi T， Fujimoto Y， et al. Abdominal sacral resection for posterior pelvic recurrence of rectal carcinoma：ana-lyses of prognostic factors and recurrence patterns[J]. Ann Surg Oncol， 2007， 14(1)：74-83.
11. Dozois EJ， Privitera A， Holubar SD， et al. High sacrectomy forlocally recurrent rectal cancer：Can long-term survival be achieved?[J]. J Surg Oncol， 2011， 103(2)：105-109.
12. Dresen RC， Gosens MJ， Rutten HJ. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer[J]. Ann Surg Oncol， 2008， 15(7)：1937-1947.
13. Valentini V， Morganti AG， Gambacorta MA， et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancerin patients previously irradiated to the pelvis：A multicentric phaseⅡstudy[J]. Int J Radiat Oncol Biol Phys， 2006， 64(4)：1129-1139.
14. Das P， Delclos ME， Skibber JM， et al. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation[J]. Int J Radiat Oncol Biol Phys， 2010， 77(1)：60-65.
15. 卫生部医政司. 结直肠癌诊疗规范(2010年版)[J/CD]. 中国医学前沿杂志：电子版， 2011， 3(6)：130-146.
16. van Gijn W， Marijnen CA， Nagtegaal ID， et al. Preoperativeradiotherapy combined with total mesorectal excision for resectablerectal cancer：12-year follow-up of the multicentre， randomised controlled TME trial[J]. Lancet Oncol， 2011， 12(6)：575-582.
17. Sauer R， Becker H， Hohenberger W， et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer[J]. N Engl J Med， 2004， 351(17)：1731-1740.
18. Grothey A， Sargent D， Goldberg RM， et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin， irinotecan， and oxaliplatin in the course of treatment[J]. J Clin Oncol， 2004， 22(7)：1209-1214.
19. Gérard JP， Conroy T， Bonnetain F， et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers：results of FFCD 9203[J]. J Clin Oncol， 2006， 24(28)：4620-4625.
20. De Caluwé L， Van Nieuwenhove Y， Ceelen WP. Preoperative chemoradiation versus radiation alone for stage Ⅱ and Ⅲ resectable rectal cancer[J]. Cochrane Database Syst Rev， 2013， 2：CD006041. doi：10. 1002/14651858. CD006041. pub3.
21. ， 47(10)：1599-1606.
22. ， 51(3)：284-291.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Current Status of Therapy for Local Recurrence of Rectal Cancer

Abstract Full text Figures/Tables Video References Cited by

Format

Content